GET DAILY SIGNALSGXPS vs IYK: Weighing Lower Costs Against Liquidity in Consumer Staples ETFs
Key Takeaways
- Both funds are passively managed consumer staples ETFs, but GXPS is a pure-play, uncapped market-cap strategy while IYK uses a capped index with a modest healthcare and materials tilt.
- GXPS is materially cheaper, with a 0.15% net expense ratio versus roughly 0.37%–0.40% for IYK.
- GXPS is more concentrated (around 31–34 holdings, top 10 near 81%), whereas IYK holds roughly 53–59 names and caps single-stock weight at 22.5%.
- IYK offers superior liquidity and a longer track record (launched in 2000, roughly $1.4 billion in assets), while GXPS is newer (2025) with a smaller asset base.
- Performance drivers diverge: GXPS leans into mega-cap retailers like WMT and COST, while IYK adds defensive healthcare exposure through names like MCK and CVS.
- Tickeron AI Verdict: GXPS — favored for its lower cost and concentrated, uncapped exposure to the sector's strongest leaders.
Why Compare These Two Staples ETFs?
Consumer staples remain a defensive cornerstone in many portfolios, covering essentials like food, beverages, and household goods that hold up across economic cycles. Comparing GXPS and IYK feels relevant now as investors balance pure sector focus with broader diversification, alongside cost considerations versus liquidity, amid evolving inflation and rate outlooks. These funds target similar defensive U.S. equity goals yet differ meaningfully in structure, fees, and holdings, making them distinct choices rather than direct substitutes.
Understanding GXPS
GXPS tracks the MSCI USA Consumer Staples Index with uncapped, free-float market-cap exposure to U.S. companies in the GICS Consumer Staples sector. Launched in July 2025, the non-diversified, passively managed ETF relies on representative sampling. Its key trait is the lack of company caps, allowing the largest names to lead the portfolio. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The fund typically holds 31–34 securities, with the top 10 accounting for roughly 81% of assets. Leading positions include WMT near 16–17%, COST around 14%, PG near 11–12%, KO around 11%, and PM near 10%. Allocation stays essentially 99–100% in consumer staples. The net expense ratio stands at 0.15% (gross 0.25%), among the lowest in the category, though assets remain modest.
Understanding IYK
IYK, launched in June 2000 by BlackRock, follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index. The benchmark caps any single issuer at 22.5% and the group above 4.5% at 45% during quarterly rebalances, resulting in a more balanced mix than an uncapped approach. It too is a non-diversified, passively managed product. The fund generally holds 53–59 securities, with top holdings such as PG and KO each near 13%, PM around 11.5%, PEP near 7%, and MO about 4%. Notably, IYK incorporates healthcare distributors like MCK and CVS, contributing roughly 13% healthcare exposure plus a small materials allocation. Its expense ratio runs about 0.37%–0.40%, with assets exceeding $1.3 billion and solid liquidity.
The Broader Consumer Staples Landscape
Both ETFs sit within a sector known for defensive, non-cyclical earnings. Recent cycles have rewarded pricing power in food and household products amid persistent inflation, while higher rate expectations have boosted appeal for lower-volatility dividend payers. Margin pressures from input costs and wage growth, along with consumer trade-down trends, pose ongoing risks. Regulatory issues around tobacco and beverages, plus antitrust focus on large retailers, add sector-level concerns. This setting tends to favor established mega-cap leaders with scale and pricing strength, which GXPS weights most heavily.
How Performance and Positioning Stack Up
Recent periods show both funds following a defensive path, yet their structures drive noticeable differences in returns. GXPS concentrates in WMT and COST, amplifying gains during staples leadership phases, while its 0.15% fee supports long-term compounding. IYK spreads exposure more evenly and includes healthcare, which can moderate volatility but may temper pure staples momentum. IYK carries a 3-year beta near 0.32–0.35, among the lowest for equity funds, and GXPS delivers comparable defensiveness with greater single-name concentration. Overall positioning leans toward GXPS for trend-focused, cost-sensitive approaches and IYK where diversification and liquidity take priority.
Enhancing ETF Research with AI Tools
In my own analysis of these funds, I frequently turn to Tickeron’s AI Screener to quickly filter holdings, compare expense ratios, and assess concentration levels across similar ETFs. It helps surface structural differences efficiently and supports more informed decisions without manual effort. The tool has become a regular part of how I evaluate sector-specific options like these.
Tickeron AI Verdict
Structural factors point Tickeron’s AI toward favoring GXPS here. Its lower expense ratio, pure consumer staples focus, and uncapped weighting in high-momentum names like WMT and COST fit well with cost-efficient, trend-aligned positioning. While IYK provides better liquidity, broader diversification, and a longer history, its higher fees and healthcare tilt reduce its edge in a pure staples context. This view remains probabilistic and based on current characteristics rather than forecasts of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IYK in upward trend: 10-day moving average broke above 50-day moving average on October 16, 2026
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for IYK just turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 32 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 62 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples
Advertisement